Antonio Francesco Maria Cicione

Pubblicazioni

Titolo	Pubblicato in	Anno
Residents and Consultants Have Equal Outcomes When Performing Transrectal Fusion Biopsies: A Randomized Clinical Trial	CURRENT ONCOLOGY	2024
Medications Mostly Associated With Ejaculatory Disorders: Assessment of the Eudra-Vigilance and Food and Drug Administration Pharmacovigilance Databases Entries	UROLOGY	2024
Quality of information and appropriateness of Open AI outputs for prostate cancer	PROSTATE CANCER AND PROSTATIC DISEASES	2024
Yoga, benign prostatic hyperplasia and lower urinary tract symptoms: a new path for clinical trials	PROSTATE CANCER AND PROSTATIC DISEASES	2024
Is early continence recovery related to the length of spared urethra? A prospective multicenter study comparing preoperative MRI and histologic specimen measurements after robotic radical prostatectomy	EUROPEAN JOURNAL OF SURGICAL ONCOLOGY	2024
Open versus Minimally Invasive Partial Nephrectomy: Trends and Outcomes from a Wide National Population-Based Database	JOURNAL OF CLINICAL MEDICINE	2024
Renal Function Preservation in Purely Off-Clamp Sutureless Robotic Partial Nephrectomy: Initial Experience and Technique	DIAGNOSTICS	2024
Purely Off-Clamp Sutureless Robotic Partial Nephrectomy for Novice Robotic Surgeons: A Multi-Institutional Propensity Score-Matched Analysis	JOURNAL OF CLINICAL MEDICINE	2024
Trends and incidence of reported events associated with ureteral stents: an analysis of the food and drug administration's manufacturer and user facility device experience (MAUDE) database	WORLD JOURNAL OF UROLOGY	2024
Post-Voided Residual Ratio Does Not Predict Trifecta Outcome after Transurethral Resection of Prostate	LIFE	2024
Major adverse cardiovascular events related to phosphodiesterase 5 inhibitors: analysis of real-life data from Eudra-Vigilance database	MINERVA UROLOGY AND NEPHROLOGY	2024
Evaluation of peri-operative outcomes after prostatic urethral lift with emphasis on urodynamic changes, symptom improvement and sexual function	DIAGNOSTICS	2024
No clinical benefit from sequential combination of mitomycin C plus bacillus Calmette-Guérin (BCG) than BCG alone in the adjuvant treatment of high risk non muscle invasive bladder cancer: result of a planned interim analysis of a prospective randomized trial	MINERVA UROLOGY AND NEPHROLOGY	2024
Patients’ Preferences and Expectations in Overactive Bladder: A Systematic Review	JOURNAL OF CLINICAL MEDICINE	2023
Physical Inactivity, Metabolic Syndrome and Prostate Cancer Diagnosis: Development of a Predicting Nomogram	METABOLITES	2023
Cardiovascular adverse events-related to GnRH agonists and GnRH antagonists: analysis of real-life data from Eudra-Vigilance and Food and Drug Administration databases entries	PROSTATE CANCER AND PROSTATIC DISEASES	2023
Development of a Pocket Nomogram to Predict Cancer and Disease Specific Survival After Radical Cystectomy For Bladder Cancer: The CRAB Nomogram	CLINICAL GENITOURINARY CANCER	2023
Medications mostly associated with hematuria: assessment of the EudraVigilance and Food and Drug Administration pharmacovigilance databases entries	MINERVA UROLOGY AND NEPHROLOGY	2023
Is EMA warning on quinolones and fluoroquinolones really assessed? An EudraVigilance database analysis	MINERVA UROLOGY AND NEPHROLOGY	2023
Cancer Stem Cells and Prostate Cancer: A Narrative Review	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2023